SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Emily Rubenstein Engel, David Kudrow, Alan M. Rapoport, A prospective, open-label study of milnacipran in the prevention of headache in patients with episodic or chronic migraine, Neurological Sciences, 2014, 35, 3, 429

    CrossRef

  2. 2
    Hans-Christoph Diener, CGRP as a new target in prevention and treatment of migraine, The Lancet Neurology, 2014, 13, 11, 1065

    CrossRef

  3. 3
    David W Dodick, Peter J Goadsby, Stephen D Silberstein, Richard B Lipton, Jes Olesen, Messoud Ashina, Kerri Wilks, David Kudrow, Robin Kroll, Bruce Kohrman, Robert Bargar, Joe Hirman, Jeff Smith, Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial, The Lancet Neurology, 2014, 13, 11, 1100

    CrossRef

  4. 4
    Frederick R. Taylor, Stephen H. Landy, Robert G. Kaniecki, Abstracts and Citations, Headache: The Journal of Head and Face Pain, 2013, 53, 8
  5. 5
    J. C. Sanderson, E. B. Devine, R. B. Lipton, L. M. Bloudek, S. F. Varon, A. M. Blumenfeld, P. J. Goadsby, D. C. Buse, S. D. Sullivan, Headache-related health resource utilisation in chronic and episodic migraine across six countries, Journal of Neurology, Neurosurgery & Psychiatry, 2013, 84, 12, 1309

    CrossRef

  6. 6
    Alberto Raggi, Ambra Mara Giovannetti, Rui Quintas, Domenico D’Amico, Alarcos Cieza, Carla Sabariego, Jerome Edmound Bickenbach, Matilde Leonardi, A systematic review of the psychosocial difficulties relevant to patients with migraine, The Journal of Headache and Pain, 2012, 13, 8, 595

    CrossRef